What is the appropriate evaluation and management for a patient with leukocytosis (WBC 24 × 10⁹/L) and elevated creatine kinase (CK)?

Evaluation and Management of Leukocytosis (WBC 24) with Elevated CK

The combination of leukocytosis (WBC 24 × 10⁹/L) and elevated CK requires immediate evaluation for muscle inflammation/injury, with priority assessment for myocardial involvement and consideration of underlying malignancy, infection, or drug-induced causes.

Initial Diagnostic Workup

The presence of both leukocytosis and elevated CK is clinically significant and demands systematic evaluation. While the provided guidelines primarily address immune checkpoint inhibitor-related myositis 1, 2, the diagnostic framework applies broadly to any patient presenting with this combination.

Essential Laboratory Testing

Immediate blood work should include:

• CK level quantification - Determine if CK is ≥3× upper limit of normal, which triggers specific management protocols 1
• Troponin - Critical to evaluate myocardial involvement, which significantly alters prognosis and management 1, 2
• Transaminases (AST, ALT), LDH, and aldolase - These are commonly elevated with muscle inflammation 1, 2
• Inflammatory markers (ESR, CRP) - Help assess degree of systemic inflammation 1, 2
• Urinalysis - Screen for myoglobinuria/rhabdomyolysis 2
• Electrolytes and renal function - Essential given risk of renal complications 3

Clinical Assessment Priorities

Focus your history and examination on:

• Muscle weakness vs. pain - Weakness is more typical of myositis than pain alone 1, 2
• Medication history - Statins, immune checkpoint inhibitors, antipsychotics, antiretrovirals can precipitate muscle injury 2, 4
• Recent seizure activity - Seizures commonly cause both elevated CK and leukocytosis 5, 3
• Signs of infection - Though isolated infection rarely causes WBC >100 × 10⁹/L 6
• Cardiac symptoms - Chest pain, dyspnea, palpitations indicating myocardial involvement 1, 2
• Skin examination - Look for dermatomyositis findings 1, 2

Differential Diagnosis Framework

Non-Malignant Causes (More Likely with WBC 24)

Reactive leukocytosis with muscle injury:

• Post-seizure state (very common cause of this combination) 5, 3
• Drug-induced myopathy with reactive leukocytosis 7, 4
• Strenuous exercise (correlation between leukocytosis and CK elevation well-established) 8
• Infection with secondary muscle involvement
• Metabolic myopathies 4

Malignant Causes (Consider but Less Likely at WBC 24)

With WBC of 24 × 10⁹/L, hematologic malignancy is less likely than with hyperleukocytosis (>100 × 10⁹/L), where 97% have underlying hematologic disease 6. However, peripheral blood smear review is still mandatory to exclude:

• Early leukemia (CML, CLL, AML)
• Lymphoma with leukemic phase
• Paraneoplastic syndrome from solid tumor 6

Risk Stratification and Management Algorithm

If CK is <3× Upper Limit Normal

• Continue diagnostic workup
• Monitor CK, ESR, CRP serially 1, 2
• Address underlying cause (stop offending medications, treat infection)
• Analgesia with acetaminophen or NSAIDs if no contraindications 1

If CK is ≥3× Upper Limit Normal

This threshold triggers more aggressive evaluation and potential treatment 1:

1. Check troponin immediately - Any myocardial involvement changes management dramatically 1, 2

2. Assess for muscle weakness:

   • If weakness present: Consider prednisone 0.5-1 mg/kg/day 1, 2
   • If no weakness: Continue monitoring, supportive care

3. Initiate rhabdomyolysis prevention (especially if CK >5000 U/L) 3:

   • Aggressive IV fluid resuscitation
   • Urine alkalinization
   • Diuretic agents as needed
   • Serial monitoring of CK, myoglobin, electrolytes, renal function

4. Consider specialist referral:

   • Rheumatology or neurology if myositis suspected 1, 2
   • Hematology if peripheral smear abnormal or clinical concern for malignancy 6

If Myocardial Involvement Confirmed

This represents a medical emergency:

• Hospitalization required 1, 2
• Cardiology consultation
• Echocardiogram or cardiac MRI 2
• If drug-induced: Permanent discontinuation of offending agent 1
• Consider prednisone 1-2 mg/kg IV methylprednisolone 1, 2

Advanced Diagnostics (When Diagnosis Uncertain)

Consider on individual basis 1, 2:

• EMG - If neurologic overlap suspected
• MRI of affected muscles - Characterize extent of involvement
• Muscle biopsy - When diagnosis remains unclear after initial workup
• Autoantibody panel - Myositis-specific antibodies, anti-AChR if myasthenia gravis overlap 2
• Genetic testing - If metabolic myopathy suspected 4

Critical Pitfalls to Avoid

1. Don't assume infection alone - Isolated infection-related hyperleukocytosis (>100) was not observed in a large cohort 6; at WBC 24, infection is possible but requires confirmation

2. Don't miss cardiac involvement - Troponin must be checked; cardiac involvement dramatically worsens prognosis and requires immediate intervention 1, 2

3. Don't overlook medication history - Statins, immune checkpoint inhibitors, antipsychotics are common culprits that require discontinuation 2, 4

4. Don't delay peripheral smear - While malignancy is less likely at WBC 24, it must be excluded early 6

5. Don't underestimate rhabdomyolysis risk - Serial CK monitoring and aggressive hydration prevent renal failure 3

The leukocytosis at 24 × 10⁹/L combined with elevated CK most commonly represents a reactive process (post-seizure, drug-induced, or exercise-related) rather than primary hematologic malignancy, but systematic evaluation is essential to identify treatable causes and prevent complications, particularly cardiac involvement and rhabdomyolysis.